A Staphylococcus aureus lipoteichoic acid (LTA) derived structural variant with two diacylglycerol residues

Stadelmaier, Andreas; Figueroa-Perez, Ignacio; Deininger, Susanne; Aulock, Sonja von; Hartung, Thomas; Schmidt, Richard R.

doi:10.1016/j.bmc.2006.05.055

Startseite
→
Biologie
→
Biologie
→
Dokumentanzeige

A Staphylococcus aureus lipoteichoic acid (LTA) derived structural variant with two diacylglycerol residues

Publikationstyp:	Zeitschriftenartikel
URI (zitierfähiger Link):	http://nbn-resolving.de/urn:nbn:de:bsz:352-opus-79685
Autor/innen:	Stadelmaier, Andreas; Figueroa-Perez, Ignacio; Deininger, Susanne; Aulock, Sonja von; Hartung, Thomas; Schmidt, Richard R.
Erscheinungsjahr:	2006
Erschienen in:	Bioorganic & Medicinal Chemistry ; 14 (2006), 18. - S. 6239-6254. - ISSN 0968-0896
Pubmed ID:	16782351
DOI (zitierfähiger Link):	https://dx.doi.org/10.1016/j.bmc.2006.05.055
Zusammenfassung:	Based on 1,2 O isopropylidene O glycerol five chiral building blocks containing differently modified glycerol residues were required for the synthesis of the target molecule 2. One of these building blocks is diacylglyceryl β gentiobioside carrying a phosphite residue at 6b O position. Ligation of these five building blocks led to the desired glycerol phosphate backbone to which D alanyl residues were attached, thus generating after O deprotection the target molecule 2, a bisamphiphilic structural variant of Staphylococcus aureus LTA. This compound displayed higher potency in terms of cytokine release by human blood leukocytes than the monoamphiphilic variant LTA.
Fachgebiet (DDC):	570 Biowissenschaften, Biologie
Link zur Lizenz:	Nutzungsbedingungen
Universitätsbibliographie:	Ja

Zitieren

Dateien zu dieser Ressource

Name: 2006Stadelmaier_galley_proofs_BMC_b ...

Größe: 268.5Kb

Format: PDF

Öffnen

Prüfsumme: MD5:946c9ddc7c6067ff2819cc1bda8c5a21

STADELMAIER, Andreas, Ignacio FIGUEROA-PEREZ, Susanne DEININGER, Sonja von AULOCK, Thomas HARTUNG, Richard R. SCHMIDT, 2006. A Staphylococcus aureus lipoteichoic acid (LTA) derived structural variant with two diacylglycerol residues. In: Bioorganic & Medicinal Chemistry. 14(18), pp. 6239-6254. ISSN 0968-0896. Available under: doi: 10.1016/j.bmc.2006.05.055

@article{Stadelmaier2006Staph-8786, title={A Staphylococcus aureus lipoteichoic acid (LTA) derived structural variant with two diacylglycerol residues}, year={2006}, doi={10.1016/j.bmc.2006.05.055}, number={18}, volume={14}, issn={0968-0896}, journal={Bioorganic & Medicinal Chemistry}, pages={6239--6254}, author={Stadelmaier, Andreas and Figueroa-Perez, Ignacio and Deininger, Susanne and Aulock, Sonja von and Hartung, Thomas and Schmidt, Richard R.} }

Figueroa-Perez, Ignacio 2011-03-24T17:46:27Z Schmidt, Richard R. eng A Staphylococcus aureus lipoteichoic acid (LTA) derived structural variant with two diacylglycerol residues Schmidt, Richard R. 2011-03-24T17:46:27Z 2006 Stadelmaier, Andreas Figueroa-Perez, Ignacio Hartung, Thomas Deininger, Susanne Stadelmaier, Andreas Hartung, Thomas Aulock, Sonja von application/pdf terms-of-use Deininger, Susanne Aulock, Sonja von First publ. in: Bioorganic & Medicinal Chemistry 14 (2006), 18, pp. 6239-6254 Based on 1,2 O isopropylidene O glycerol five chiral building blocks containing differently modified glycerol residues were required for the synthesis of the target molecule 2. One of these building blocks is diacylglyceryl β gentiobioside carrying a phosphite residue at 6b O position. Ligation of these five building blocks led to the desired glycerol phosphate backbone to which D alanyl residues were attached, thus generating after O deprotection the target molecule 2, a bisamphiphilic structural variant of Staphylococcus aureus LTA. This compound displayed higher potency in terms of cytokine release by human blood leukocytes than the monoamphiphilic variant LTA.